Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 4 | 2015 | 248 | 1.150 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2015 | 81 | 1.040 |
Why?
|
| Vocalization, Animal | 2 | 2015 | 54 | 0.740 |
Why?
|
| Receptors, Dopamine D1 | 3 | 2015 | 45 | 0.730 |
Why?
|
| Signal Transduction | 5 | 2015 | 2111 | 0.660 |
Why?
|
| Frontal Lobe | 2 | 2011 | 58 | 0.640 |
Why?
|
| Cytidine Diphosphate Diglycerides | 2 | 2010 | 2 | 0.610 |
Why?
|
| Antidepressive Agents | 2 | 2010 | 61 | 0.580 |
Why?
|
| Dopamine | 3 | 2015 | 272 | 0.540 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2015 | 81 | 0.530 |
Why?
|
| Hippocampus | 3 | 2010 | 591 | 0.520 |
Why?
|
| Amphetamine | 1 | 2015 | 21 | 0.470 |
Why?
|
| Dopamine Agonists | 3 | 2009 | 34 | 0.450 |
Why?
|
| Corpus Striatum | 3 | 2011 | 119 | 0.430 |
Why?
|
| Central Nervous System Stimulants | 1 | 2015 | 181 | 0.410 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2015 | 1737 | 0.370 |
Why?
|
| Phosphatidylinositols | 2 | 2010 | 14 | 0.370 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 79 | 0.340 |
Why?
|
| Receptors, Dopamine | 1 | 2011 | 30 | 0.340 |
Why?
|
| Protein Isoforms | 1 | 2011 | 139 | 0.330 |
Why?
|
| Maprotiline | 1 | 2010 | 3 | 0.330 |
Why?
|
| Paroxetine | 1 | 2010 | 3 | 0.330 |
Why?
|
| Imipramine | 1 | 2010 | 9 | 0.330 |
Why?
|
| Rats | 8 | 2015 | 3701 | 0.320 |
Why?
|
| Biogenic Monoamines | 1 | 2010 | 32 | 0.320 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2008 | 3 | 0.300 |
Why?
|
| Type C Phospholipases | 1 | 2008 | 24 | 0.300 |
Why?
|
| Reward | 1 | 2009 | 106 | 0.290 |
Why?
|
| Maternal Exposure | 1 | 2008 | 56 | 0.270 |
Why?
|
| Depressive Disorder | 1 | 2008 | 185 | 0.250 |
Why?
|
| Neurons | 2 | 2011 | 1246 | 0.220 |
Why?
|
| DNA Methylation | 1 | 2008 | 393 | 0.220 |
Why?
|
| Animals | 10 | 2015 | 16695 | 0.210 |
Why?
|
| Receptor, trkB | 2 | 2015 | 19 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 1112 | 0.180 |
Why?
|
| Brain | 1 | 2008 | 1452 | 0.160 |
Why?
|
| Male | 7 | 2015 | 22779 | 0.150 |
Why?
|
| Motor Activity | 2 | 2010 | 438 | 0.130 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2015 | 35 | 0.120 |
Why?
|
| Cytosol | 2 | 2012 | 98 | 0.110 |
Why?
|
| ras Proteins | 1 | 2014 | 54 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 159 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 1804 | 0.110 |
Why?
|
| Time Factors | 2 | 2009 | 1848 | 0.110 |
Why?
|
| Mice | 3 | 2010 | 6490 | 0.100 |
Why?
|
| Transfection | 1 | 2014 | 526 | 0.100 |
Why?
|
| Receptor, Endothelin B | 1 | 2012 | 4 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 255 | 0.100 |
Why?
|
| Endothelin-1 | 1 | 2012 | 57 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 436 | 0.090 |
Why?
|
| Calcium | 2 | 2012 | 487 | 0.090 |
Why?
|
| Narcotics | 1 | 2011 | 30 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2012 | 108 | 0.090 |
Why?
|
| Receptors, Opioid | 1 | 2011 | 40 | 0.090 |
Why?
|
| Buprenorphine | 1 | 2011 | 51 | 0.090 |
Why?
|
| Detergents | 1 | 2011 | 25 | 0.090 |
Why?
|
| Biophysical Phenomena | 1 | 2010 | 22 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2011 | 154 | 0.080 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 58 | 0.080 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2010 | 15 | 0.080 |
Why?
|
| Diacylglycerol Cholinephosphotransferase | 1 | 2010 | 31 | 0.080 |
Why?
|
| PC12 Cells | 1 | 2010 | 93 | 0.080 |
Why?
|
| Indole Alkaloids | 1 | 2009 | 14 | 0.080 |
Why?
|
| Ultrasonics | 1 | 2009 | 15 | 0.080 |
Why?
|
| Injections, Intraventricular | 1 | 2009 | 59 | 0.080 |
Why?
|
| Dopamine Antagonists | 1 | 2009 | 48 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2012 | 381 | 0.080 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2009 | 10 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2012 | 324 | 0.080 |
Why?
|
| Carbazoles | 1 | 2009 | 46 | 0.080 |
Why?
|
| Serotonin | 1 | 2010 | 125 | 0.080 |
Why?
|
| Quinpirole | 1 | 2009 | 18 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2014 | 449 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2009 | 139 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2011 | 400 | 0.070 |
Why?
|
| Psychotropic Drugs | 1 | 2008 | 17 | 0.070 |
Why?
|
| Methylation | 1 | 2008 | 118 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 128 | 0.070 |
Why?
|
| Anti-Anxiety Agents | 1 | 2008 | 17 | 0.070 |
Why?
|
| CpG Islands | 1 | 2008 | 107 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 303 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2008 | 462 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 456 | 0.070 |
Why?
|
| Brain Chemistry | 1 | 2008 | 140 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 574 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 457 | 0.070 |
Why?
|
| Antipsychotic Agents | 1 | 2008 | 81 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 649 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 303 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2008 | 1010 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2008 | 534 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 55 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 188 | 0.030 |
Why?
|
| Microcirculation | 1 | 2012 | 40 | 0.020 |
Why?
|
| Endosomes | 1 | 2012 | 34 | 0.020 |
Why?
|
| Fura-2 | 1 | 2011 | 13 | 0.020 |
Why?
|
| Lysosomes | 1 | 2012 | 88 | 0.020 |
Why?
|
| beta-Endorphin | 1 | 2011 | 16 | 0.020 |
Why?
|
| Naltrexone | 1 | 2011 | 34 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 88 | 0.020 |
Why?
|
| Narcotic Antagonists | 1 | 2011 | 78 | 0.020 |
Why?
|
| Autophagy | 1 | 2012 | 136 | 0.020 |
Why?
|
| Morphine | 1 | 2011 | 68 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 448 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 182 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2012 | 383 | 0.020 |
Why?
|
| Ligands | 1 | 2011 | 387 | 0.020 |
Why?
|
| Humans | 2 | 2014 | 42163 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 711 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 1617 | 0.020 |
Why?
|
| Female | 1 | 2008 | 24018 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 2598 | 0.020 |
Why?
|